Qube Research & Technologies (QRT)
ANIX icon

Qube Research & Technologies (QRT)’s Anixa Biosciences ANIX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,519
Closed -$186K – 3516
2025
Q4 		$186K Buy
+59,519
New +$244K ﹤0.01% 3074
2024
Q3 		– Sell
-3
Closed -$6 – 3265
2024
Q2 		$6 Sell
3
-93,340
-100% -$265K ﹤0.01% 3639
2024
Q1 		$291K Buy
93,343
+44,890
+93% +$179K ﹤0.01% 2832
2023
Q4 		$188K Buy
48,453
+48,449
+1,211,225% +$163K ﹤0.01% 2814
2023
Q3 		$13 Buy
+4
New +$14 ﹤0.01% 3909
2023
Q1 		– Sell
-22,712
Closed -$96.5K – 2513
2022
Q4 		$96.5K Buy
+22,712
New +$109K ﹤0.01% 2014
2021
Q2 		– Sell
-13,293
Closed -$62K – 2230
2021
Q1 		$62K Sell
13,293
-64,989
-83% -$311K ﹤0.01% 1773
2020
Q4 		$240K Sell
78,282
-58,575
-43% -$147K ﹤0.01% 1454
2020
Q3 		$333K Buy
136,857
+110,249
+414% +$284K ﹤0.01% 1195
2020
Q2 		$81K Buy
+26,608
New +$55.2K ﹤0.01% 1542

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ANIX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Anixa Biosciences (ANIX) in Q1 2026, closing a stake of 59,519 shares — an estimated $186K sold.

Qube Research & Technologies (QRT) first reported a position in ANIX in Q2 2020 and held it in 10 quarters. The position peaked at $333K in Q3 2020. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Anixa Biosciences position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 59,519 Anixa Biosciences shares in Q1 2026, an estimated $186K.
  • Qube Research & Technologies (QRT) first reported a position in Anixa Biosciences in Q2 2020 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Anixa Biosciences position peaked at $333K in Q3 2020.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.